CA Stock MarketDetailed Quotes

Fennec Pharmaceuticals Inc (FRX)

Watchlist
  • 13.310
  • +0.660+5.22%
15min DelayPost Market May 15 15:55 ET
462.35MMarket Cap-28.50P/E (TTM)

Fennec Pharmaceuticals Inc (FRX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-146.23%-12.47M
-304.48%-5.96M
167.68%1.49M
56.05%-3.69M
-111.06%-4.32M
257.38%26.98M
69.67%-1.47M
20.07%-2.21M
-112.54%-8.39M
800.14%39.05M
Net income from continuing operations
-2,134.17%-9.74M
-141.16%-4.79M
88.89%-637K
43.24%-3.15M
-109.08%-1.17M
97.28%-436K
25.99%-1.99M
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
Operating gains losses
--2.02M
----
----
----
----
----
----
----
----
----
Depreciation and amortization
-87.13%103K
0.00%26K
4.00%26K
-3.85%25K
-96.40%26K
--800K
--26K
--25K
150.00%26K
1,290.38%723K
Remuneration paid in stock
-33.43%2.88M
1,571.36%3.33M
-140.57%-1.67M
--1.14M
--79K
--4.32M
--199K
--4.12M
--0
--0
Unrealized gains and losses of investment securities
-97.53%2K
----
----
--1K
-90.91%1K
107.69%81K
----
----
--0
-63.33%11K
Remuneration paid in stock
38.96%7.03M
124.38%2.52M
21.86%2.22M
61.51%1.49M
-33.00%798K
-5.47%5.06M
31.16%1.12M
110.52%1.82M
-63.63%925K
9.37%1.19M
Other non cashItems
-1,391.94%-2.73M
-184.86%-2.77M
-95.83%14K
-96.96%13K
-96.89%13K
-26.48%211K
-49.38%-971K
-57.58%336K
242.40%428K
1,990.00%418K
Change In working capital
-171.07%-12.04M
-12,228.85%-6.31M
155.92%1.55M
23.81%-3.21M
-117.05%-4.07M
349.97%16.94M
102.15%52K
-9.64%-2.76M
-276.83%-4.21M
3,433.38%23.87M
-Change in receivables
-58.01%-12.44M
-1,876.00%-3.46M
18.10%-3.44M
87.00%-265K
-261.44%-5.28M
-8.31%-7.87M
95.92%-175K
-101.92%-4.2M
-167.45%-2.04M
-957.97%-1.46M
-Change in inventory
-320.73%-1.28M
113.85%139K
-154.98%-276K
-896.25%-797K
-473.91%-344K
136.65%579K
116.21%65K
258.86%502K
84.64%-80K
126.90%92K
-Change in prepaid assets
-30.30%-658K
-16,607.14%-2.34M
154.38%3.34M
-2,205.50%-2.3M
133.25%636K
-585.58%-505K
96.66%-14K
525.24%1.31M
-40.11%109K
-1,560.31%-1.91M
-Change in payables and accrued expense
517.27%3.6M
237.57%703K
559.34%1.4M
102.07%43K
-28.55%1.45M
-143.94%-863K
-119.05%-511K
8.68%-305K
-12,147.06%-2.08M
654.50%2.04M
-Change in other current assets
-259.17%-1.27M
-296.80%-1.35M
42.86%520K
183.61%102K
-303.76%-537K
26,433.33%796K
22,800.00%687K
--364K
---122K
---133K
-Change in other current liabilities
----
----
--0
--2K
-100.01%-2K
----
----
---437K
--0
--25.25M
-Change in other working capital
----
----
----
----
----
--24.81M
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-146.23%-12.47M
-304.48%-5.96M
167.68%1.49M
56.05%-3.69M
-111.06%-4.32M
257.38%26.98M
69.67%-1.47M
20.07%-2.21M
-112.54%-8.39M
800.14%39.05M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
266.19%22.63M
270.35%20.8M
431.25%1.75M
-210.51%-284K
131.71%359K
-305.11%-13.62M
-313.12%-12.21M
-362.69%-528K
-50.00%257K
-686.53%-1.13M
Net issuance payments of debt
-49.82%-19.48M
----
----
----
----
-360.16%-13M
----
----
----
----
Net common stock issuance
--42.05M
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
68.33%2.19M
-74.28%205K
482.77%1.8M
-153.31%-185K
-40.83%371K
-24.18%1.3M
6.69%797K
-318.60%-470K
-35.86%347K
194.37%627K
Net other financing activities
-11.43%-2.14M
-21,833.33%-1.97M
13.79%-50K
-10.00%-99K
99.32%-12K
-2,454.67%-1.92M
35.71%-9K
-314.29%-58K
-233.33%-90K
-8,695.00%-1.76M
Cash from discontinued financing activities
Financing cash flow
266.19%22.63M
270.35%20.8M
431.25%1.75M
-210.51%-284K
131.71%359K
-305.11%-13.62M
-313.12%-12.21M
-362.69%-528K
-50.00%257K
-686.53%-1.13M
Net cash flow
Beginning cash position
100.72%26.63M
-45.57%21.95M
-56.55%18.71M
-55.70%22.68M
100.72%26.63M
-44.19%13.27M
225.19%40.32M
187.83%43.05M
178.33%51.18M
-44.19%13.27M
Current changes in cash
-24.03%10.15M
208.44%14.84M
218.58%3.24M
51.17%-3.97M
-110.44%-3.96M
227.23%13.37M
-1,673.10%-13.69M
-6.84%-2.73M
-136.89%-8.13M
804.22%37.92M
End cash Position
38.12%36.79M
38.12%36.79M
-45.57%21.95M
-56.55%18.71M
-55.70%22.68M
100.72%26.63M
100.72%26.63M
225.19%40.32M
187.83%43.05M
178.33%51.18M
Free cash from
-146.23%-12.47M
-304.48%-5.96M
167.68%1.49M
56.05%-3.69M
-111.06%-4.32M
257.38%26.98M
69.67%-1.47M
20.07%-2.21M
-112.54%-8.39M
800.14%39.05M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -146.23%-12.47M-304.48%-5.96M167.68%1.49M56.05%-3.69M-111.06%-4.32M257.38%26.98M69.67%-1.47M20.07%-2.21M-112.54%-8.39M800.14%39.05M
Net income from continuing operations -2,134.17%-9.74M-141.16%-4.79M88.89%-637K43.24%-3.15M-109.08%-1.17M97.28%-436K25.99%-1.99M-207.18%-5.74M-2.00%-5.55M312.11%12.84M
Operating gains losses --2.02M------------------------------------
Depreciation and amortization -87.13%103K0.00%26K4.00%26K-3.85%25K-96.40%26K--800K--26K--25K150.00%26K1,290.38%723K
Remuneration paid in stock -33.43%2.88M1,571.36%3.33M-140.57%-1.67M--1.14M--79K--4.32M--199K--4.12M--0--0
Unrealized gains and losses of investment securities -97.53%2K----------1K-90.91%1K107.69%81K----------0-63.33%11K
Remuneration paid in stock 38.96%7.03M124.38%2.52M21.86%2.22M61.51%1.49M-33.00%798K-5.47%5.06M31.16%1.12M110.52%1.82M-63.63%925K9.37%1.19M
Other non cashItems -1,391.94%-2.73M-184.86%-2.77M-95.83%14K-96.96%13K-96.89%13K-26.48%211K-49.38%-971K-57.58%336K242.40%428K1,990.00%418K
Change In working capital -171.07%-12.04M-12,228.85%-6.31M155.92%1.55M23.81%-3.21M-117.05%-4.07M349.97%16.94M102.15%52K-9.64%-2.76M-276.83%-4.21M3,433.38%23.87M
-Change in receivables -58.01%-12.44M-1,876.00%-3.46M18.10%-3.44M87.00%-265K-261.44%-5.28M-8.31%-7.87M95.92%-175K-101.92%-4.2M-167.45%-2.04M-957.97%-1.46M
-Change in inventory -320.73%-1.28M113.85%139K-154.98%-276K-896.25%-797K-473.91%-344K136.65%579K116.21%65K258.86%502K84.64%-80K126.90%92K
-Change in prepaid assets -30.30%-658K-16,607.14%-2.34M154.38%3.34M-2,205.50%-2.3M133.25%636K-585.58%-505K96.66%-14K525.24%1.31M-40.11%109K-1,560.31%-1.91M
-Change in payables and accrued expense 517.27%3.6M237.57%703K559.34%1.4M102.07%43K-28.55%1.45M-143.94%-863K-119.05%-511K8.68%-305K-12,147.06%-2.08M654.50%2.04M
-Change in other current assets -259.17%-1.27M-296.80%-1.35M42.86%520K183.61%102K-303.76%-537K26,433.33%796K22,800.00%687K--364K---122K---133K
-Change in other current liabilities ----------0--2K-100.01%-2K-----------437K--0--25.25M
-Change in other working capital ----------------------24.81M----------------
Cash from discontinued investing activities
Operating cash flow -146.23%-12.47M-304.48%-5.96M167.68%1.49M56.05%-3.69M-111.06%-4.32M257.38%26.98M69.67%-1.47M20.07%-2.21M-112.54%-8.39M800.14%39.05M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 266.19%22.63M270.35%20.8M431.25%1.75M-210.51%-284K131.71%359K-305.11%-13.62M-313.12%-12.21M-362.69%-528K-50.00%257K-686.53%-1.13M
Net issuance payments of debt -49.82%-19.48M-----------------360.16%-13M----------------
Net common stock issuance --42.05M------------------0----------------
Proceeds from stock option exercised by employees 68.33%2.19M-74.28%205K482.77%1.8M-153.31%-185K-40.83%371K-24.18%1.3M6.69%797K-318.60%-470K-35.86%347K194.37%627K
Net other financing activities -11.43%-2.14M-21,833.33%-1.97M13.79%-50K-10.00%-99K99.32%-12K-2,454.67%-1.92M35.71%-9K-314.29%-58K-233.33%-90K-8,695.00%-1.76M
Cash from discontinued financing activities
Financing cash flow 266.19%22.63M270.35%20.8M431.25%1.75M-210.51%-284K131.71%359K-305.11%-13.62M-313.12%-12.21M-362.69%-528K-50.00%257K-686.53%-1.13M
Net cash flow
Beginning cash position 100.72%26.63M-45.57%21.95M-56.55%18.71M-55.70%22.68M100.72%26.63M-44.19%13.27M225.19%40.32M187.83%43.05M178.33%51.18M-44.19%13.27M
Current changes in cash -24.03%10.15M208.44%14.84M218.58%3.24M51.17%-3.97M-110.44%-3.96M227.23%13.37M-1,673.10%-13.69M-6.84%-2.73M-136.89%-8.13M804.22%37.92M
End cash Position 38.12%36.79M38.12%36.79M-45.57%21.95M-56.55%18.71M-55.70%22.68M100.72%26.63M100.72%26.63M225.19%40.32M187.83%43.05M178.33%51.18M
Free cash from -146.23%-12.47M-304.48%-5.96M167.68%1.49M56.05%-3.69M-111.06%-4.32M257.38%26.98M69.67%-1.47M20.07%-2.21M-112.54%-8.39M800.14%39.05M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More